Incidence and risk factors of prolonged QTc interval in type 1 diabetes - The EURODIAB Prospective Complications Study

被引:32
|
作者
Giunti, Sara
Bruno, Graziella
Lillaz, Emma
Gruden, Gabriella
Lolli, Valentina
Chaturvedi, Nish
Fuller, John H.
Veglio, Massimo
Cavallo-Perin, Paolo
机构
[1] Univ Turin, Dept Internal Med, I-10126 Turin, Italy
[2] Imperial Coll Sch Med, Int Ctr Circulatory Hlth & Natl Heart & Lung Inst, London, England
[3] Osped Evangelico Valdese, Turin, Italy
基金
英国惠康基金;
关键词
D O I
10.2337/dc07-0063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Corrected QT (QTc) prolongation is predictive of cardiovascular mortality in both the general and diabetic populations. As part of the EURODIAB Prospective Complication Study, we have assessed the 7-year incidence and risk factors of prolonged QTc in people with type 1 diabetes. RESEARCH DESIGN AND METHODS - A total of 1,415 type 1 diabetic subjects, who had normal QTc at baseline, were reanalyzed after the 7-year follow-up period. QTc >0.44 s was considered abnormally prolonged. RESULTS - Cumulative incidence of prolonged QTc was 18.7%, which is twofold higher in women than in men (24.5 vs. 13.9%, P < 0.0001). At the baseline examination, incident cases were older and less physically active than nonincident cases, had higher mean values of systolic blood pressure and HDL cholesterol, and had higher frequencies of hypertension, coronary heart disease, and distal symmetrical polyneuropathy. In multivariate logistic regression analyses, female sex and higher values of A I C and systolic blood pressure were associated with the risk of prolonged QTc. whereas physical activity and BMI within the range of 21.5-23.2 kg/m(2) were protective factors. In women, association with modifiable factors, particularly BMI, was stronger than in men. CONCLUSIONS - in type I diabetic subjects from the EURODIAB cohort, female sex, A 1 C, and systolic blood pressure are predictive of prolonged QTc, whereas physical activity and BMI within the range of 21.5-23.2 kg/m(2) play a protective role. These findings are clinically relevant, as they may help to identify subjects at higher risk for prolonged QTc, as well as provide potential targets for risk-lowering strategies.
引用
收藏
页码:2057 / 2063
页数:7
相关论文
共 50 条
  • [1] Incidence of prolonged QTc and severe hypoglycemia in type 1 diabetes: the EURODIAB Prospective Complications Study
    Amione, Cristina
    Giunti, Sara
    Fornengo, Paolo
    Soedamah-Muthu, Sabita S.
    Chaturvedi, Nish
    Fuller, J. H.
    Barutta, Federica
    Gruden, Gabriella
    Bruno, Graziella
    ACTA DIABETOLOGICA, 2017, 54 (09) : 871 - 876
  • [2] Incidence of prolonged QTc and severe hypoglycemia in type 1 diabetes: the EURODIAB Prospective Complications Study
    Cristina Amione
    Sara Giunti
    Paolo Fornengo
    Sabita S. Soedamah-Muthu
    Nish Chaturvedi
    J. H. Fuller
    Federica Barutta
    Gabriella Gruden
    Graziella Bruno
    Acta Diabetologica, 2017, 54 : 871 - 876
  • [3] Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes - The EURODIAB Prospective Complications Study
    Chaturvedi, N
    Sjoelie, AK
    Porta, M
    Aldington, SJ
    Fuller, JH
    Songini, M
    Kohner, EM
    DIABETES CARE, 2001, 24 (02) : 284 - 289
  • [4] Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes The EURODIAB Prospective Complications Study
    Gruden, Gabriella
    Barutta, Federica
    Chaturvedi, Nish
    Schalkwijk, Casper
    Stehouwer, Coen D.
    Witte, Daniel R.
    Fuller, John H.
    Perin, Paolo Cavallo
    Bruno, Graziella
    DIABETES CARE, 2012, 35 (07) : 1598 - 1604
  • [5] Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study
    Soraya Soulimane
    Beverley Balkau
    Yakima D. Vogtschmidt
    Monika Toeller
    John H. Fuller
    Sabita S. Soedamah-Muthu
    Diabetologia, 2022, 65 : 1169 - 1178
  • [6] Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study
    Soulimane, Soraya
    Balkau, Beverley
    Vogtschmidt, Yakima D.
    Toeller, Monika
    Fuller, John H.
    Soedamah-Muthu, Sabita S.
    DIABETOLOGIA, 2022, 65 (07) : 1169 - 1178
  • [7] Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study
    J. W. J. Beulens
    J. S. Kruidhof
    D. E. Grobbee
    N. Chaturvedi
    J. H. Fuller
    S. S. Soedamah-Muthu
    Diabetologia, 2008, 51 : 1631 - 1638
  • [8] Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study
    Beulens, J. W. J.
    Kruidhof, J. S.
    Grobbee, D. E.
    Chaturvedi, N.
    Fuller, J. H.
    Soedamah-Muthu, S. S.
    DIABETOLOGIA, 2008, 51 (09) : 1631 - 1638
  • [9] Incidence and determinants of microalbuminuria in Type 1 diabetes: the Italian cohort of the EURODIAB Prospective Complications study.
    Bandinelli, S
    Penno, G
    Pucci, L
    Miccoli, R
    Del Prato, S
    Reboldi, P
    Santeusanio, F
    DIABETOLOGIA, 2002, 45 : A360 - A361
  • [10] Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes. The EURODIAB Prospective Complications study
    Soulimane, S.
    Vogtschmidt, Y. D.
    Toeller, M.
    Balkau, B.
    Chaturvedi, N.
    Fuller, J. H.
    Soedamah-Muthu, S. S.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S4 - S4